Laughter TherapyNCT07020962
Effect of Laughter Therapy on Breast Cancer Patients
A study testing laughter therapy and routine nursing care in people with Laughter Therapy and Psychological Well-being, run by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization.
Trial summary
The aim of this study is to examine the effect of laughter therapy applied to breast cancer patients before surgical intervention on distress, depression and psychological well-being of patients. This research will be carried out as an experimental research with a randomised control group. Read more about this study
- Who is it for?
- Ages 18 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Laughter Therapy, Psychological Well-being, Breast Cancer
- What is being tested?
- laughter therapy and routine nursing care
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 56 participants
- Where
- No sites listed yet
- Study dates
- 25 Jun 2025to 30 Oct 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Voluntary acceptance to participate in the study,
- Being diagnosed with breast cancer and being in the patient group in which surgical operation is planned,
- Not having participated in laughter yoga practice before,
- Being literate,
- Not having a psychiatric disease (diagnosis)
- Not having a communication and understanding disability related to vision, hearing
- Being in the age group of 18 and over
Who cannot join
- Not wanting to participate in the study,
- Being in the patient group with a condition recommended not to do laughter yoga (having undergone surgery in the abdominal region in the last three months, uncontrolled hypertension, glaucoma, hernia, epilepsy),
- Not having participated in any of the laughter yoga sessions,
- Having physical restriction/respiratory problems and not being able to perform yoga movements.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: The Effect of Laughter Therapy on Distress, Depression and Psychological Well-being in Breast Cancer Patients Before Surgical Intervention: A Randomised Controlled Trial
The aim of this study is to examine the effect of laughter therapy applied to breast cancer patients before surgical intervention on distress, depression and psychological well-being of patients.
This research will be carried out as an experimental research with a randomised control group.
Read more
The population of the study will consist of breast cancer patients diagnosed with breast cancer in a city hospital and scheduled for surgery in the breast-endocrine surgery clinic. The research will be carried out with patients who meet the inclusion criteria and agree to participate in the study. The sample size for the study was calculated using the G* Power 3.1.9.7 programme (Faul et al., 2007). In the calculation, since there was no similar study for two-way mixed design analysis of variance, the required sample size was calculated as 48, 24 in each group, based on the medium effect size (effect size f=0.25), 5% margin of error (alpha=0.05), inter-measurement correlation value 0.5 and 80% power (1-β=0.80). Considering the data losses, the number was increased by 20% and a total of 56 patients in the intervention and control groups constituted the sample of the study.
Hypothesis(es):
H1: The effect of laughter therapy applied to breast cancer patients on distress over time is different in the experimental and control groups.
H2: The effect of laughter therapy applied to breast cancer patients on depression over time is different in the experimental and control groups.
H3: The effect of laughter therapy applied to breast cancer patients on psychological well-being according to time is different in experimental and control groups.
In obtaining the research data; Personal Information Form, Distress Thermometer, Psychological well-being scale prepared by the researchers in line with the literature will be used.
The research data will be collected face-to-face through data collection forms from breast cancer patients diagnosed with breast cancer and scheduled for surgery in the breast-endocrine surgery clinic. Individuals who agree to participate in the study and meet the inclusion criteria will be assigned to the experimental and control groups by providing randomisation. Which caregivers will be in the intervention group and which will be in the control group will be determined according to the randomisation table determined by https://www.randomizer.org/ over the internet. Group 1: Intervention Group, Group 2: Control Group. Data collection tools will be applied to the individuals in the experimental and control groups as a pre-test. Individuals in the experimental group will receive laughter therapy three days a week for 30-45 minutes (6 sessions). Individuals in the control group will receive only standard nursing care. Data collection tools will be applied to the individuals in both groups for post-test, 1 and 3-month follow-up tests immediately after all laughter sessions with the experimental group are completed.
Read the detailed description
Breast cancer is described as a type of disease caused by the uncontrolled proliferation of cells surrounding the milk glands and ducts in the breast. Breast cancer is the most common type of cancer in women in the world and in our country. According to GLOBOCAN 2022 data, breast cancer constitutes 23.8% of all female cancers, and it was reported that 2.3 million women worldwide and 25 thousand women in Turkey were diagnosed with breast cancer in 2022.
As a result of mastectomy or breast conserving treatment, breast cancer can bring about various negative consequences such as body image and sexual life disorder. Women diagnosed with breast cancer often experience psychological problems such as fear of cancer recurrence, deterioration of body perception, decreased self-esteem, loss of femininity and fear of death, and cancer diagnosis and treatment can lead to anxiety, depression and anger in patients. Studies have reported that diagnosis, treatment outcomes, and the course of the disease are associated with depressive symptoms .Depressive symptoms have been identified as one of the most common complications in patients with breast cancer. Depression and anxiety are common diagnoses following breast cancer diagnosis and are vital as effective ways to identify patients at risk for psychological distress.
Psychosocial distress has long been identified as an important problem for breast cancer patients who face challenges in many different areas. The National Comprehensive Cancer Network (NCCN) has recognised distress as an important sequela of cancer diagnosis and treatment. In a qualitative study examining the preoperative distress and anxiety experiences of breast cancer patients, it was reported that the anxiety and distress of these patients increased mostly before surgery, but they were also affected by the care experiences surrounding their surgery. Formally, cancer-related distress is defined as 'a multifactorial unpleasant emotional experience of a psychological (i.e. cognitive, behavioural, emotional), social or spiritual nature that may interfere with the ability to cope effectively with cancer, its physical symptoms and treatment'. In addition, the definition of distress has drawn attention to the early identification and treatment of emotional distress in cancer, and the conceptualisation of psychological distress as the 6th vital sign has provided a framework for care providers to understand emotional difficulties in cancer patients. In a systematic review, it was reported that unmanaged distress negatively affects cancer-related morbidity and mortality as well as quality of life.
The diagnosis and treatment process of breast cancer may increase the level of depression and psychological distress and have a negative impact on the psychological well-being of patients. Psychological well-being is defined as the individual's self-actualisation, using his/her existing or unrealised potential in the most efficient way, accepting himself/herself with this potential, having life goals, establishing qualified relationships and feeling responsibility for his/her own life . It is stated that individuals with high levels of psychological well-being not only feel good about themselves, but also are more successful in interpersonal relationships, their life energy and creativity increase, their immune systems are strengthened, and they are more productive in business life. In the light of this information, considering that having cancer is one of the most stressful life events, psychological well-being levels should be increased in order to overcome the negative consequences of being diagnosed with breast cancer.
In recent years, laughter therapy has attracted attention among methods of coping with stress. Laughter therapy/yoga, which is classified as complementary therapy in medicine, is a unique form of exercise consisting of a combination of laughter, yoga and breathing techniques that allow us to laugh without any sense of humour. Although it is a different approach from other therapeutic methods, it focuses on the approach that both body and mind can only be healthy when the psychological aspects of the brain change. Laughter yoga can be used as a nursing intervention to reduce the symptoms of different diseases and relieve general stress. Laughter yoga has been registered by the NIC (classification of nursing interventions) authority at the University of Iowa since 2023 and has been included in the latest version of the NIC. In this context, it is envisaged that laughter yoga as a nursing initiative will be widely used in nursing research and education in caring for both sick and healthy individuals.
It is reported that humour and laughter yoga are humane, allow the improvement of the experience in the hospital environment, and contribute to the development of communication and trust between the nurse and the individual while providing care. In addition, it enables the person to participate in care and treatment, helps to increase comfort, helps to cope with difficult and unpleasant situations, reduces anger, tension, stress, increases the person's tolerance to pain, and strengthens the immune system.
As a result of a systematic review and metanalysis, it was suggested that nurses should actively transform this therapy into clinical practice to alleviate the negative emotions of patients and teach these methods to patients and their relatives as part of health education to improve treatment outcomes. In the same study, it was concluded that laughter yoga is a multimodality flexible therapy suitable for improving the negative emotions of cancer patients. However, it is stated that in order to evaluate the effect of laughter therapy on patient outcomes in cancer patients, studies with larger samples, different cancer types, long-term follow-ups, and more randomised controlled designs should be conducted. It was also stated that more studies are needed to show whether laughter therapy reduces depressive symptoms in cancer patients.
It is also recommended that future studies try to obtain more precise results regarding the effect of laughter therapy by extending the intervention time in cancer patients.
It is a very exciting and innovative practice for nurses to use laughter yoga to protect and improve the health of individuals. In our country, a limited number of studies have been conducted on laughter yoga, which has become increasingly widespread and its benefits have been scientifically approved. In addition, no study has been found in our country that examines the effect of laughter therapy on the distress, depression and psychological well-being levels of patients before the surgical procedure in breast cancer patients. Considering the gaps in the literature, this study aimed to investigate the effect of laughter therapy applied to breast cancer patients before surgical intervention on distress, depression and psychological well-being levels of patients in a randomised controlled longitudinal study.
- Conditions
- Laughter Therapy, Psychological Well-being, Breast Cancer, Distress, Depression
- Being tested
- laughter therapy, routine nursing care
- Keywords
- breast cancer, psychological well-being, depression, distress, laughter therapy
- Medical subject headings
- Psychological Well-Being, Breast Neoplasms, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
laughter therapyOther
Laughter therapy/yoga, classified as complementary therapy in medicine, is a unique form of exercise consisting of a combination of laughter, yoga and breathing techniques that allows us to laugh without any sense of humour.
routine nursing careOther
routine nursing care
| Study group | Role | What they receive |
|---|---|---|
| Experimental group | Experimental | Laughter therapy Receives: Other: laughter therapy |
| control group | Active comparator | routine nursing care Receives: Other: routine nursing care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Laughter therapy will be applied to individuals with breast cancer and their levels of psychological distress will be measured.Laughter therapy will be applied to individuals with breast cancer and their psychological distress levels will be measured.
Meme kanserine sahip olan bireylere kahkaha terapisi uygulanacak ve pskilojik sıkıntı düzeyleri ölçülecektir.
Laughter therapy will be applied to individuals with breast cancer and their levels of psychological distress will be measured. (Face to face training will be given)
Measured: 2 weeks
Laughter therapy will be applied to individuals with breast cancer and their depression levels will be measured.
Laughter therapy will be applied to individuals with breast cancer and their depression levels will be measured (Face to face training will be given)
Measured: 2 weeks
Laughter therapy will be applied to individuals with breast cancer and their psychological well-being levels will be measured.
Laughter therapy will be applied to individuals with breast cancer and their psychological well-being levels will be measured (Face to face training will be given)
Measured: 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jun 2025
- Study start25 Jun 2025 (estimated)
- Primary completion30 Aug 2025 (estimated)
- Study completion30 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Laughter TherapyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 56 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Servet CİHAN, Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
- Investigators
- Servet Cihan, Principal investigator, Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07020962
- Sponsor's protocol ID
- ServetCİHAN
- Status last verified
- Jun 2025
- First submitted
- 25 Apr 2025
- Last updated
- 13 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Laughter Therapy on Distress, Depression and Psychological Well-being in Breast Cancer Patients Before Surgical Intervention: A Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT07020962
- Acronym / sponsor ID
- ServetCİHAN
- Conditions
- Laughter Therapy, Psychological Well-being, Breast Cancer, Distress, Depression
- Keywords
- breast cancer, psychological well-being, depression, distress, laughter therapy
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 56 participants (estimated)
- Lead sponsor
- Prof. Dr. Cemil Tascıoglu Education and Research Hospital OrganizationUniversity, hospital or other
- Study start
- 25 Jun 2025 (estimated)
- Primary completion
- 30 Aug 2025 (estimated)
- Study completion
- 30 Oct 2025 (estimated)
- First posted
- 13 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to examine the effect of laughter therapy applied to breast cancer patients before surgical intervention on distress, depression and psychological well-being of patients.
This research will be carried out as an experimental research with a randomised control group.
The population of the study will consist of breast cancer patients diagnosed with breast cancer in a city hospital and scheduled for surgery in the breast-endocrine surgery clinic. The research will be carried out with patients who meet the inclusion criteria and agree to participate in the study. The sample size for the study was calculated using the G* Power 3.1.9.7 programme (Faul et al., 2007). In the calculation, since there was no similar study for two-way mixed design analysis of variance, the required sample size was calculated as 48, 24 in each group, based on the medium effect size (effect size f=0.25), 5% margin of error (alpha=0.05), inter-measurement correlation value 0.5 and 80% power (1-β=0.80). Considering the data losses, the number was increased by 20% and a total of 56 patients in the intervention and control groups constituted the sample of the study.
Hypothesis(es):
H1: The effect of laughter therapy applied to breast cancer patients on distress over time is different in the experimental and control groups.
H2: The effect of laughter therapy applied to breast cancer patients on depression over time is different in the experimental and control groups.
H3: The effect of laughter therapy applied to breast cancer patients on psychological well-being according to time is different in experimental and control groups.
In obtaining the research data; Personal Information Form, Distress Thermometer, Psychological well-being scale prepared by the researchers in line with the literature will be used.
The research data will be collected face-to-face through data collection forms from breast cancer patients diagnosed with breast cancer and scheduled for surgery in the breast-endocrine surgery clinic. Individuals who agree to participate in the study and meet the inclusion criteria will be assigned to the experimental and control groups by providing randomisation. Which caregivers will be in the intervention group and which will be in the control group will be determined according to the randomisation table determined by https://www.randomizer.org/ over the internet. Group 1: Intervention Group, Group 2: Control Group. Data collection tools will be applied to the individuals in the experimental and control groups as a pre-test. Individuals in the experimental group will receive laughter therapy three days a week for 30-45 minutes (6 sessions). Individuals in the control group will receive only standard nursing care. Data collection tools will be applied to the individuals in both groups for post-test, 1 and 3-month follow-up tests immediately after all laughter sessions with the experimental group are completed.
Detailed description
Breast cancer is described as a type of disease caused by the uncontrolled proliferation of cells surrounding the milk glands and ducts in the breast. Breast cancer is the most common type of cancer in women in the world and in our country. According to GLOBOCAN 2022 data, breast cancer constitutes 23.8% of all female cancers, and it was reported that 2.3 million women worldwide and 25 thousand women in Turkey were diagnosed with breast cancer in 2022.
As a result of mastectomy or breast conserving treatment, breast cancer can bring about various negative consequences such as body image and sexual life disorder. Women diagnosed with breast cancer often experience psychological problems such as fear of cancer recurrence, deterioration of body perception, decreased self-esteem, loss of femininity and fear of death, and cancer diagnosis and treatment can lead to anxiety, depression and anger in patients. Studies have reported that diagnosis, treatment outcomes, and the course of the disease are associated with depressive symptoms .Depressive symptoms have been identified as one of the most common complications in patients with breast cancer. Depression and anxiety are common diagnoses following breast cancer diagnosis and are vital as effective ways to identify patients at risk for psychological distress.
Psychosocial distress has long been identified as an important problem for breast cancer patients who face challenges in many different areas. The National Comprehensive Cancer Network (NCCN) has recognised distress as an important sequela of cancer diagnosis and treatment. In a qualitative study examining the preoperative distress and anxiety experiences of breast cancer patients, it was reported that the anxiety and distress of these patients increased mostly before surgery, but they were also affected by the care experiences surrounding their surgery. Formally, cancer-related distress is defined as 'a multifactorial unpleasant emotional experience of a psychological (i.e. cognitive, behavioural, emotional), social or spiritual nature that may interfere with the ability to cope effectively with cancer, its physical symptoms and treatment'. In addition, the definition of distress has drawn attention to the early identification and treatment of emotional distress in cancer, and the conceptualisation of psychological distress as the 6th vital sign has provided a framework for care providers to understand emotional difficulties in cancer patients. In a systematic review, it was reported that unmanaged distress negatively affects cancer-related morbidity and mortality as well as quality of life.
The diagnosis and treatment process of breast cancer may increase the level of depression and psychological distress and have a negative impact on the psychological well-being of patients. Psychological well-being is defined as the individual's self-actualisation, using his/her existing or unrealised potential in the most efficient way, accepting himself/herself with this potential, having life goals, establishing qualified relationships and feeling responsibility for his/her own life . It is stated that individuals with high levels of psychological well-being not only feel good about themselves, but also are more successful in interpersonal relationships, their life energy and creativity increase, their immune systems are strengthened, and they are more productive in business life. In the light of this information, considering that having cancer is one of the most stressful life events, psychological well-being levels should be increased in order to overcome the negative consequences of being diagnosed with breast cancer.
In recent years, laughter therapy has attracted attention among methods of coping with stress. Laughter therapy/yoga, which is classified as complementary therapy in medicine, is a unique form of exercise consisting of a combination of laughter, yoga and breathing techniques that allow us to laugh without any sense of humour. Although it is a different approach from other therapeutic methods, it focuses on the approach that both body and mind can only be healthy when the psychological aspects of the brain change. Laughter yoga can be used as a nursing intervention to reduce the symptoms of different diseases and relieve general stress. Laughter yoga has been registered by the NIC (classification of nursing interventions) authority at the University of Iowa since 2023 and has been included in the latest version of the NIC. In this context, it is envisaged that laughter yoga as a nursing initiative will be widely used in nursing research and education in caring for both sick and healthy individuals.
It is reported that humour and laughter yoga are humane, allow the improvement of the experience in the hospital environment, and contribute to the development of communication and trust between the nurse and the individual while providing care. In addition, it enables the person to participate in care and treatment, helps to increase comfort, helps to cope with difficult and unpleasant situations, reduces anger, tension, stress, increases the person's tolerance to pain, and strengthens the immune system.
As a result of a systematic review and metanalysis, it was suggested that nurses should actively transform this therapy into clinical practice to alleviate the negative emotions of patients and teach these methods to patients and their relatives as part of health education to improve treatment outcomes. In the same study, it was concluded that laughter yoga is a multimodality flexible therapy suitable for improving the negative emotions of cancer patients. However, it is stated that in order to evaluate the effect of laughter therapy on patient outcomes in cancer patients, studies with larger samples, different cancer types, long-term follow-ups, and more randomised controlled designs should be conducted. It was also stated that more studies are needed to show whether laughter therapy reduces depressive symptoms in cancer patients.
It is also recommended that future studies try to obtain more precise results regarding the effect of laughter therapy by extending the intervention time in cancer patients.
It is a very exciting and innovative practice for nurses to use laughter yoga to protect and improve the health of individuals. In our country, a limited number of studies have been conducted on laughter yoga, which has become increasingly widespread and its benefits have been scientifically approved. In addition, no study has been found in our country that examines the effect of laughter therapy on the distress, depression and psychological well-being levels of patients before the surgical procedure in breast cancer patients. Considering the gaps in the literature, this study aimed to investigate the effect of laughter therapy applied to breast cancer patients before surgical intervention on distress, depression and psychological well-being levels of patients in a randomised controlled longitudinal study.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (care provider)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental group | Experimental | Other: laughter therapyLaughter therapy |
| control group | Active comparator | Other: routine nursing careroutine nursing care |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Voluntary acceptance to participate in the study,
- Being diagnosed with breast cancer and being in the patient group in which surgical operation is planned,
- Not having participated in laughter yoga practice before,
- Being literate,
- Not having a psychiatric disease (diagnosis)
Key exclusion criteria (4 listed)
- Not wanting to participate in the study,
- Being in the patient group with a condition recommended not to do laughter yoga (having undergone surgery in the abdominal region in the last three months, uncontrolled hypertension, glaucoma, hernia, epilepsy),
- Not having participated in any of the laughter yoga sessions,
- Having physical restriction/respiratory problems and not being able to perform yoga movements.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| laughter therapyLaughter therapy/yoga, classified as complementary therapy in medicine, is a unique form of exercise consisting of a combination of laughter, yoga and breathing techniques that allows us to laugh without any sense of humour. | Other | Experimental group |
| routine nursing careroutine nursing care | Other | control group |
Primary outcome
Laughter therapy will be applied to individuals with breast cancer and their levels of psychological distress will be measured.Laughter therapy will be applied to individuals with breast cancer and their psychological distress levels will be measured.
Time frame: 2 weeks
Meme kanserine sahip olan bireylere kahkaha terapisi uygulanacak ve pskilojik sıkıntı düzeyleri ölçülecektir. Laughter therapy will be applied to individuals with breast cancer and their levels of psychological distress will be measured. (Face to face training will be given)
Laughter therapy will be applied to individuals with breast cancer and their depression levels will be measured.
Time frame: 2 weeks
Laughter therapy will be applied to individuals with breast cancer and their depression levels will be measured (Face to face training will be given)
Laughter therapy will be applied to individuals with breast cancer and their psychological well-being levels will be measured.
Time frame: 2 weeks
Laughter therapy will be applied to individuals with breast cancer and their psychological well-being levels will be measured (Face to face training will be given)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jun 2025.
- Individual participant dataSharing planned: No
Related trials for Laughter Therapy
Enrolling by invitation
Effects of Laughter Therapy on Respiratory Functions and Geriatric Pain in Elderly Individuals
Elderly, Respiratory Function
Recruiting
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
Acute Lymphoblastic Leukemia ALL
Enrolling by invitationObservational study
Exploring the Evolution of Quality of Life and Emotional Distress Among Cancer Patients Participating in Mind-body Therapies
Cancer, Mind-Body Therapies
Not yet recruitingPhase 3
Sustained Mood Improvement With Laughing Gas Exposure
Major Depressive Disorder, Treatment Resistant Depression
Not yet recruiting
The Effect of Laughter Yoga Practice in Hypertension Patients
Hypertension, Laughter Yoga
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Servet Cihan principal investigator
Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi
Questions about this trial
What is this clinical trial studying?
A study testing laughter therapy and routine nursing care in people with Laughter Therapy and Psychological Well-being, run by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 13 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Servet Cihan (5456925693, servetcihann@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Laughter therapy will be applied to individuals with breast cancer and their levels of psychological distress will be measured.Laughter therapy will be applied to individuals with breast cancer and their psychological distress levels will be measured. (time frame: 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2025.